TY - JOUR AU - Jones, N. B. AU - Iwenofu, H. AU - Scharschmidt, T. AU - Kraybill, W. PY - 2012 DA - 2012// TI - Prognostic factors and staging for soft tissue sarcomas: an update JO - Surg Oncol Clin N Am VL - 21 UR - https://doi.org/10.1016/j.soc.2011.12.003 DO - 10.1016/j.soc.2011.12.003 ID - Jones2012 ER - TY - CHAP AU - Benjamin, R. AU - Pisters Peter, W. T. AU - Helman, L. J. AU - Bramwell Vivien, H. C. AU - Rubin, B. P. AU - O′Sullivan, B. ED - Abeloff, M. D. ED - Armitage, J. O. ED - Niederhuber, J. E. ED - Kastan, M. B. ED - McKeena, W. G. PY - 2008 DA - 2008// TI - Sarcomas of Soft Tissue BT - Clinical Oncology PB - Churchill Livingstone Elsevier CY - Philadelphia, PA ID - Benjamin2008 ER - TY - JOUR AU - Ducimetière, F. AU - Lurkin, A. AU - Ranchère-Vince, D. AU - Decouvelaere, A. V. AU - Pèoc'h, M. AU - Istier, L. PY - 2011 DA - 2011// TI - Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0020294 DO - 10.1371/journal.pone.0020294 ID - Ducimetière2011 ER - TY - STD TI - American Cancer Society. Sarcoma - Adult Soft Tissue Cancer. Atlanta, GA: American Cancer Society, 2014. [http://www.cancer.org/acs/groups/cid/documents/webcontent/003138-pdf.pdf] UR - http://www.cancer.org/acs/groups/cid/documents/webcontent/003138-pdf.pdf ID - ref4 ER - TY - JOUR AU - Coindre, J. M. AU - Terrier, P. AU - Guillou, L. AU - Doussal, V. AU - Collin, F. AU - Ranchère, D. PY - 2001 DA - 2001// TI - Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group JO - Cancer VL - 91 UR - https://doi.org/3.0.CO;2-3 DO - 3.0.CO;2-3 ID - Coindre2001 ER - TY - JOUR AU - Leahy, M. AU - Garcia del Muro, X. AU - Reichardt, P. AU - Judson, I. AU - Staddon, A. AU - Verweij, J. PY - 2012 DA - 2012// TI - Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mds070 DO - 10.1093/annonc/mds070 ID - Leahy2012 ER - TY - STD TI - National Comprehensive Cancer Network. Soft Tissue Sarcoma. NCCN Clinical Practice Guidelines in Oncology, 2012. [https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf] UR - https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf ID - ref7 ER - TY - JOUR PY - 2012 DA - 2012// TI - Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up JO - Ann Oncol VL - 23 ID - ref8 ER - TY - STD TI - National Cancer Institute. Drugs Approved for Soft Tissue Sarcoma. National Cancer Institute, 2012. [http://www.cancer.gov/cancertopics/druginfo/softtissuesarcoma] UR - http://www.cancer.gov/cancertopics/druginfo/softtissuesarcoma ID - ref9 ER - TY - JOUR AU - Graaf, W. T. AU - Blay, J. Y. AU - Chawla, S. P. AU - Kim, D. W. AU - Bui-Nguyen, B. AU - Casali, P. G. PY - 2012 DA - 2012// TI - Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial JO - Lancet VL - 379 UR - https://doi.org/10.1016/S0140-6736(12)60651-5 DO - 10.1016/S0140-6736(12)60651-5 ID - Graaf2012 ER - TY - STD TI - US Food and Drug Administration. Votrient (Pazopanib) Tablets: For Treatment of Patients with Soft Tissue Sarcoma. FDA Oncologic Drugs Advisory Committee Briefing Document (NDA 22-465). March 2012. [http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM296303.pdf] UR - http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM296303.pdf ID - ref11 ER - TY - JOUR AU - Demetri, G. D. AU - Chawla, S. P. AU - Mehren, M. AU - Ritch, P. AU - Baker, L. H. AU - Blay, J. Y. PY - 2009 DA - 2009// TI - Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.21.0088 DO - 10.1200/JCO.2008.21.0088 ID - Demetri2009 ER - TY - JOUR AU - Maki, R. G. AU - Wathen, J. K. AU - Patel, S. R. AU - Priebat, D. A. AU - Okuno, S. H. AU - Samuels, B. PY - 2007 DA - 2007// TI - Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected] JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.10.4117 DO - 10.1200/JCO.2006.10.4117 ID - Maki2007 ER - TY - JOUR AU - Oosterom, A. T. AU - Mouridsen, H. T. AU - Nielsen, O. S. AU - Dombernowsky, P. AU - Krzemieniecki, K. AU - Judson, I. PY - 2002 DA - 2002// TI - Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients JO - Eur J Cancer VL - 38 UR - https://doi.org/10.1016/S0959-8049(02)00491-4 DO - 10.1016/S0959-8049(02)00491-4 ID - Oosterom2002 ER - TY - JOUR AU - Garcia del Muro, X. AU - Lopez Pousa, A. AU - Martin, J. AU - Buesa, J. M. AU - Martinez Trufero, J. AU - Casado, A. PY - 2005 DA - 2005// TI - A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish group for research on sarcomas JO - Cancer VL - 104 UR - https://doi.org/10.1002/cncr.21384 DO - 10.1002/cncr.21384 ID - Garcia del Muro2005 ER - TY - JOUR AU - Butrynski, J. E. AU - Duh, M. AU - Fournier, A. AU - Moyneur, E. AU - Dial, E. AU - Neary, M. P. PY - 2008 DA - 2008// TI - Soft tissue sarcoma (STS): challenges in identification, treatment patterns, and costs of disease management in the US [abstract] JO - J Clin Oncol VL - 26 ID - Butrynski2008 ER - TY - CHAP AU - Howlader, N. AU - Noone, A. AU - Krapcho, M. AU - Neyman, N. AU - Aminou, R. AU - Altekruse, S. F. PY - 2012 DA - 2012// TI - SEER Stat Fact Sheets: Soft Tissue including Heart BT - SEER Cancer Statistics Review, 1975–2009 PB - National Cancer Institute; 2012; based on November 2011 SEER data submission, posted to the SEER web site CY - Bethesda, MD ID - Howlader2012 ER - TY - JOUR AU - Italiano, A. AU - Mathoulin-Pelissier, S. AU - Cesne, A. L. AU - Terrier, P. AU - Bonvalot, S. AU - Collin, F. PY - 2011 DA - 2011// TI - Trends in survival for patients with metastatic soft-tissue sarcoma JO - Cancer VL - 117 UR - https://doi.org/10.1002/cncr.25538 DO - 10.1002/cncr.25538 ID - Italiano2011 ER - TY - STD TI - Bedi M, King DM, Charlson J, Whitfield R, Hackbarth DA, Zambrano EV, Wang D. Multimodality management of metastatic patients with soft tissue sarcomas may prolong survival. Am J Clin Oncol. 2014;37:272–7. ID - ref19 ER - TY - JOUR AU - Penel, N. AU - Glabbeke, M. AU - Marreaud, S. AU - Ouali, M. AU - Blay, J. Y. AU - Hohenberger, P. PY - 2011 DA - 2011// TI - Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years JO - Ann Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdq608 DO - 10.1093/annonc/mdq608 ID - Penel2011 ER -